Lipoprotein Lipase Protein (LPL) (Myc-DYKDDDDK Tag)

N° du produit ABIN2724832

Détail du produit

Antigène: Lipoprotein Lipase (LPL)

Type de proteíne: Recombinant

Origine: Humain

Source: HEK-293 Cells

Purification/Conjugué: Cette Lipoprotein Lipase protéine est marqué à la Myc-DYKDDDDK Tag.

Application: Antibody Production (AbP), Standard (STD)

Attributs du produit:

• Recombinant human Lipoprotein lipase protein expressed in HEK293 cells.
• Produced with end-sequenced ORF clone

Pureté: > 80 % as determined by SDS-PAGE and Coomassie blue staining

Information d'application

Indications d'application: Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays

Commentaires:

The tag is located at the C-terminal.

Restrictions: For Research Use only

Stockage

Concentration: 50 μg/mL

Buffer: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.

Stock: -80 °C

Stockage commentaire: Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.

Détail du antigène

Antigène: Lipoprotein Lipase (LPL)

Autre désignation: Lipoprotein Lipase (LPL Produits)

Synonymes: HDLCQ11 Protein, LIPD Protein, fb62e04 Protein, fc49b03 Protein, wu:fb62e04 Protein, wu:fc49b03 Protein, LPL Protein, lipd Protein, hdlcq11 Protein, lpl Protein, LOC100223817 Protein, lipoprotein lipase Protein, LPL Protein, Lpl Protein, lpl Protein

Sujet: LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism.

Poids moléculaire: 50.3 kDa

NCBI Accession: NP_000228

Pathways: Lipid Metabolism